South Florida Hospital News
Tuesday July 14, 2020

test 2

July 2020 - Volume 17 - Issue 1


Tenet Florida Physician Services (TFPS) announces Harry Shufflebarger, M.D., a pediatric orthopedic surgeon specializing in pediatric spine surgery, is relocating his practice to the Paley Orthopedic & Spine Institute in West Palm Beach.

Prior to joining TFPS and the Paley Orthopedic & Spine Institute, Dr. Shufflebarger served as Chief of the Department of Orthopedic Surgery, then Director, Division of Spinal Surgery at Nicklaus Children’s Hospital, formerly known as Miami Children’s Hospital. Dr. Shufflebarger is currently a distinguished clinical professor in the Department of Orthopedics and Rehabilitation at the University of Miami School of Medicine, located in Miami, FL. Dr. Shufflebarger was named the President of the Scoliosis Research Society (SRS) in 1999, a distinction he held after serving several different roles within the organization from 1993-2006. He received the Lifetime Achievement Award from the Scoliosis Research Society in 2016.
Aaron Huser, D.O., an orthopaedic surgeon and limb deformity specialist, has also opened his practice at the Paley Orthopedic & Spine Institute in West Palm Beach.
Prior to joining TFPS and the Paley Orthopedic & Spine Institute, Dr. Huser worked as a pediatric orthopedic surgeon at Gillette Children’s Specialty Healthcare in St. Paul, MN.
For his education and training, Dr. Huser completed a fellowship in limb deformity at Paley Orthopedic & Spine Institute (2017-2018) and a pediatric orthopaedic fellowship at Washington University and St. Louis Children’s Hospital in St. Louis, MO. Dr. Huser finished his orthopaedic surgery residency and served as Chief Resident at Rowan University and Inspira Health Network located in Vineland, NJ. He completed his internship at Michigan State University and Henry Ford Macomb Hospital in Clinton Township, MI. Dr. Huser graduated medical school from Midwestern University and Chicago College of Osteopathic Medicine located in Downers Grove, IL.

Dr. Robert Hanfland, congenital heart surgeon, has joined The Heart Program at Nicklaus Children's Hospital.

Dr. Hanfland is board certified in general surgery and thoracic surgery. He is a member of the Society of Thoracic Surgeons and an associate member of Women in Thoracic Surgery. Dr. Hanfland has been part of national committees for the Congenital Heart Surgeons Society, as well as the Society of Thoracic Surgeons.
Dr. Hanfland earned his medical degree from Southern Illinois University in Springfield and completed a residency in general surgery at University of Iowa Hospitals & Clinics in Iowa City. He then pursued a fellowship in cardiothoracic surgery at University of Iowa Hospitals & Clinics and an additional fellowship in congenital heart surgery at Children’s Hospital Colorado in Denver. His clinical interests include ethics in medicine, pediatric cardiology, congenital heart surgery, hypoplastic left heart syndrome and other complicated pediatric heart anomalies.

Primary care physician John Woltz, D.O., has joined Baptist Health to provide general, preventive and occupational medicine services to his patients in the Florida Keys. He is affiliated with Mariners Hospital and Fishermen’s Community Hospital and will see patients at Baptist Health Primary Care in Marathon, FL.

He has treated patients in a diverse range of settings, including rural clinics, hospitals and major urban healthcare facilities. Dr. Woltz has extensive experience working with military and civilian populations. He retired from the United States Air Force as a lieutenant colonel after a 28-year career.
Dr. Woltz joins Baptist Health from Hocking Valley Medical Group in Ohio, where he served as medical director of a 13-provider, 36-person staff in rural Appalachia. He also was the chief of aerospace medicine and the public health emergency officer at Wright-Patterson Medical Center on the Wright-Patterson Air Force Base.
Dr. Woltz earned his medical degree from the Ohio University Heritage College of Osteopathic Medicine and completed a residency in occupational medicine at the University of Cincinnati. He is board-certified in occupational medicine. In addition to his medical degree, Dr. Woltz holds a Master of Science in public health from the University of Cincinnati.

Elizabeth Steinberg, M.D., a pediatrician, has joined Broward Health Physician Group. Her primary practice is located at Broward Health Weston and and she is affiliated with Salah Foundation Children’s Hospital. Steinberg has been practicing medicine in general pediatrics since 2012 and her special interest is in newborn care, asthma and developmental issues.

Prior to joining Broward Health, Steinberg worked as a physician in the pediatric emergency department at King’s County Hospital in New York. She is a professional member of the American Academy of Pediatrics.
Steinberg earned a Bachelor of Arts in Psychology with a minor in biology from Temple University. She received her medical degree from St. George’s University School of Medicine in West Indies, Grenada. Dr. Steinberg completed her residency in pediatrics at SUNY Downstate College of Medicine in New York.

Broward Health Medical Center resumed medical diagnostic screenings and elective surgeries in early May. In addition to these services now available to the community, and although the COVID-19 pandemic continues, new treatments and technologies for a variety of conditions have been launched to enhance care and extend patient access for the South Florida community.

Broward Health Medical Center recently installed the Hologic Clarity HD 3D mammography system with the SmartCurve compression paddle at the Women’s Health Center.
“This new mammography system provides a more comfortable and accurate mammogram experience,” said Regional Manager of Radiology Judith Zavatsky. “We are also able to provide 3D guided breast biopsy, which enables us to biopsy the very small lesions being found with this superior technology.”
Also, in May, the first SpineJack procedure in Broward County was performed at Broward Health Medical Center. The surgery is an outpatient procedure and takes about 20 minutes.
“This is a minimally invasive procedure,” said Behnam Myers, D.O., and orthopedic spine surgeon. “The SpineJack elevates the broken bone like a car jack, and then we fill the area with a cement to hold in place. This allows for more alignment of the back and less chance of pain in the future.”
Broward Health launched the first OPTION clinical study on the Watchman FLX, with the first patients undergoing the implantation of the device on June 11, 2020. Broward Health Medical Center is the first hospital in South Florida to enroll patients for this national study that uses this second-generation Watchman device.
“This is a tremendous benefit for patients to protect them from having a stroke without being on an anticoagulant for the rest of your life,” said Ahmed Osman, M.D., Broward Health Physician Group. “This is a game changer for those patients who would otherwise have to be on an anticoagulant indefinitely with the additional risk of bleeding on injury since a lot of these patients lead very active lifestyles. This device also is successful suited to fit all anatomies as compared to the previous device.”
Broward Health’s mission is to provide high quality care to all those we serve. These new technologies further that mission while creating greater access to advanced care close to home.

Specialized imaging of the brain is making minimally invasive treatments possible at Cleveland Clinic Martin Health.

Neuro-interventionalist Jeffrey Miller, M.D., uses biplane fluoroscopy to navigate the intricate channels of blood vessels in the brain. This is an important ingredient in the endovascular coiling and mechanical thrombectomy procedures he performs.
Dr. Miller uses endovascular coiling to repair a brain aneurysm before it ruptures. He accesses the brain through an artery in the pelvis and fills the aneurysm with soft coils to divert blood flow away from it. This reduces the risk of the aneurysm bleeding or rupturing.
The elective procedure can take between 30 minutes and two hours to complete and the majority of patients are able to go home the next day.
Brain aneurysms are not uncommon, but many people may experience no symptoms until they rupture. Dr. Miller encourages people to be proactive with their health and talk with their primary care physician if they have a family history of brain aneurysms. Screening can help locate an aneurysm before it ruptures.
“Don’t be afraid to be screened,” said Dr. Miller. “Most people have a very negative connotation about brain aneurysms, but the technology and procedures have come dramatically far.”
This technology is also used in the treatment of ischemic strokes, where a blood clot is obstructing blood flow to the brain. Similar to endovascular coiling, Dr. Miller accesses the brain through an artery in the pelvis and performs a mechanical thrombectomy to remove the clot. The results can be life-changing.
“It’s very exciting,” said Dr. Miller. “To see someone come into the hospital paralyzed and walk out, I can’t imagine anything more rewarding.”
By 2050, approximately 16 million Americans and 60 million people worldwide will be affected by Alzheimer’s disease (AD) and related disorders (ADRD), which include Lewy Body Dementia (LBD), Parkinson’s disease, vascular dementia and frontotemporal degeneration. In Florida alone, individuals diagnosed with AD is expected to increase by 40 percent in the next 15 years. These alarming projections highlight the urgent need to employ a multifaceted and personalized approach that targets prevention, early diagnosis and treatment of dementia.
Florida Atlantic University’s Schmidt College of Medicine and The Harry T. Mangurian, Jr. Foundation have joined forces again to usher in a new phase of research to prevent dementia. Through the extension of a three-year, $3 million grant from the Foundation’s ADRD Medical Research Fund, FAU’s Schmidt College of Medicine will launch the new FAU Center for Brain Health within its FAU Medicine Primary Care Practice. The grant supports precision medicine approaches to prevent dementia, which will be further strengthened by leveraging multiple patient-centered platforms through state-of-the-art transdisciplinary approaches.
Leading the initiative is Janet Robishaw, Ph.D., a renowned scientist in functional and translational genomics, senior associate dean for research and chair of the Department of Biomedical Sciences in FAU’s Schmidt College of Medicine, and a member of the FAU Brain Institute (I-BRAIN). Robishaw has been working at the forefront of precision medicine for more than a decade. She will oversee the new FAU Center for Brain Health research team to leverage resources and collaborations to increase research, shorten the time for meaningful study results and enhance research impact by including multiple sites and diverse patient populations.
Funding from The Harry T. Mangurian, Jr. Foundation grant will enable Robishaw to secure research equipment, key personnel, and other related costs necessary to ensure the successful launch of the new FAU Center for Brain Health. The project will utilize precision-medicine approaches to characterize individuals with ADRD with the goal of stratifying and developing individualized treatment plans. The funding will also support the recruitment of a leading clinician scientist with expertise in personalized approaches to preventing and treating the full spectrum of dementias. This individual will work collaboratively with Robishaw and other FAU scientists who are dedicated to research in this field.
Robishaw and the FAU Center for Brain Health team will continue to support, share, and disseminate new knowledge to communities and beyond by administering pilot grants, hosting national meetings, and developing state-of-the-art curricular materials. FAU and its team of funded researchers in ADRD will continue to serve as a vital hub for advancing science and education in the prevention and treatment of dementia. 

Five physicians in Lakeside Medical Center’s Family Medicine Residency Program recently graduated in a virtual ceremony following three years of training that included a new medical condition, COVID-19. The teaching hospital is located in the heart of Palm Beach County’s rural, western communities, which is considered a hot spot for the virus.

“I can’t tell you how proud I am of this class of residents,” said Darcy J. Davis, CEO of the Health Care District of Palm Beach County. “You’ve been with us during the toughest times Lakeside Medical Center has faced and fought on the front lines of the COVID-19 pandemic. I commend you for your courage, determination and dedication to the Glades community.
The five graduates, Danny Abouekde, D.O., Samuel Espinal, D.O., David Lepoff, D.O., and Chief Residents Nergess Taheri, D.O., and Terry Parsons, D.O., completed a rigorous three-year curriculum. Their rotations included emergency medicine, women’s health care, pediatrics, psychiatry, general surgery, internal medicine, community and sports medicine, cardiology, dermatology, women’s health, radiology, orthopedics, ENT, urology, ophthalmology and critical care.
This year the residency program was accredited by the Accreditation Council for Graduate Medical Education (ACGME), a distinction that assures Lakeside Medical Center’s Family Medicine Residency Program meets the quality standards of the specialty or subspecialty practices for which it prepares its graduates.

Curaleaf Holdings, Inc. announced that it has signed an amended agreement for its acquisition of GR Companies, Inc. ("Grassroots"), the largest private vertically-integrated multi-state operator in the United States.

Joseph Lusardi, CEO of Curaleaf, stated, "This announcement marks another significant step forward in finalizing our acquisition of Grassroots, providing Curaleaf an important entry to highly populous, vertically integrated markets in the Midwest. The pending integration of Grassroots will solidify Curaleaf's position as the world's largest cannabis company by revenue and the most well-diversified, vertically integrated cannabis company in the United States, the world's largest cannabis market. We are well positioned to continue to lead our growing industry, and we look forward to closing the transaction and serving new patients and customers in the Grassroots community."
On July 17, 2019, Curaleaf announced the signing of a definitive agreement to acquire Grassroots. Under the new mutually agreed and amended terms of the agreement, the principal component of the transaction consideration remains the same at approximately 102.8 million subordinate voting shares ("SVS") of Curaleaf. What had initially been a $75 million cash component of the consideration has been eliminated, while the component of additional Curaleaf SVS to be priced at the 10-day volume-weighted average price prior to closing of the transaction has been increased from $40 million to approximately $90.1 million, subject to final adjustment. Accordingly, the total SVS consideration for the transaction is expected to be approximately 118.9 million shares(1). Curaleaf and Grassroots mutually aligned on the updated terms in support of the further optimization of cash, providing maximum flexibility to support the future growth of the business following the close of the transaction. In addition, the parties have resolved that certain Grassroots assets in Illinois, Ohio and Maryland will be designated for sale after closing to comply with local limitation on license ownership. The transaction price remains subject to usual working capital and other adjustments. Curaleaf's acquisition of Grassroots is currently expected to close upon completion of certain pre-closing conditions within the coming weeks.
Grassroots is a strong market leader throughout the Midwest, with an affiliated portfolio of over 50 dispensary licenses, including more than 30 operational dispensaries. The transaction is expected to strategically accelerate Curaleaf's expansion into Illinois and Pennsylvania, which are among the largest and fastest-growing cannabis markets in the United States. Grassroots also has a leading presence in new state markets in which Curaleaf does not currently operate, including Arkansas, North Dakota, and Vermont. The transaction is also complementary to Curaleaf's existing business in seven other states, providing additional scale and operating leverage in major markets such as Arizona, Maryland, Michigan, and Ohio.
The planned integration of Grassroots is expected to expand Curaleaf's presence from 18 to 23 states, with the combined company having over 135 dispensary licenses, 88 operational dispensary locations, over 30 processing facilities and 22 cultivation sites with 1.6 million square feet of current cultivation capacity.
At closing, security holders in Grassroots will have approximately 18% pro forma ownership of Curaleaf on a fully-diluted basis. The amended terms of the transaction were unanimously approved by the Boards of Directors at both companies. A copy of the amended transaction agreement with respect to the proposed transaction will be filed under Curaleaf's profile on SEDAR at
Upon closing of the transaction, the core security holders of Grassroots will have, as a group, the right to appoint one person to serve on the Curaleaf Board of Directors. Mitch Kahn, co-founder and CEO of Grassroots, will fill the allotted board seat. Kahn co-founded Grassroots in 2014 and brings with him more than 20 years of executive experience.

Bluma Wellness Inc. is pleased to announce that its subsidiary company, One Plant Florida, has opened its latest dispensary retail location and delivery hub in Port St. Lucie, Florida.

“We have set the standard of cultivating the best cannabis in Florida and, with one of the most experienced cannabis cultivation teams, we are proud of the product we grow”
Situated in the heart of Florida’s Treasure Coast, this location offers patients in Port St. Lucie, as well as patients in Indian River, St. Lucie, Martin and North Palm Beach County areas (via delivery), access to One Plant’s top-shelf genetics, hang-dried and hand-trimmed flower, vape products, concentrates and merchandise via an in-store experience, curbside pickup or home delivery.
One Plant Florida is a vertically integrated, licensed cannabis company and one of 14 operational medical marijuana treatment centers (MMTC) in Florida. The company’s retail dispensary sites are carefully selected to promote efficient delivery of premium flower to Florida’s patients. The Port St. Lucie location is One Plant’s fourth retail location in Florida. The company expects to open several additional locations throughout the state before the end of the year.
One Plant strives to provide top-quality, best-in-class cannabis and cannabis-derived products. It hand-picks its premium cannabis flowers, which are sold as flower, pre-rolls, distillate and in concentrate form. Offerings include prime and rare strains of cannabis flower such as Mac1, Runtz, SherbD, ChemD, Chem91, I75, Fish Whistle, Dirty Lemons, and Ebony and Ivory, among others. It also sells vaporizers, vaporizer accessories, and vaping cartridges.
“We have set the standard of cultivating the best cannabis in Florida and, with one of the most experienced cannabis cultivation teams, we are proud of the product we grow,” said Bluma Wellness Inc. CEO Brady Cobb. “Through our commitment to honoring the fullest expression of each seed, post-harvest trimming, curing and packaging cannabis flower products, we have established One Plant as a premier supplier of cannabis products. We look forward to sharing our passion with the Treasure Coast community.”
Recognizing the diverse needs of its patients, One Plant provides a robust delivery service across most of Florida. It also offers curbside pickup at all retail locations. Orders can be placed online, and customers can use CanPay for payment. A loyalty rewards program is offered as well.
Consumers must have a medical marijuana card to purchase products.
<< 11 thru 20 out of 20
Share |